BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31613803)

  • 1. A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
    Suzuki K; Naito T; Tanaka H; Yamada Y; Itoh K; Kawakami J
    Ther Drug Monit; 2020 Jun; 42(3):503-511. PubMed ID: 31613803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomeric determination of tramadol and its main metabolite O-desmethyltramadol in human plasma by liquid chromatography-tandem mass spectrometry.
    Ceccato A; Vanderbist F; Pabst JY; Streel B
    J Chromatogr B Biomed Sci Appl; 2000 Oct; 748(1):65-76. PubMed ID: 11092587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics.
    de Moraes NV; Lauretti GR; Napolitano MN; Santos NR; Godoy AL; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):140-7. PubMed ID: 22173007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of the enantiomers of tramadol and its three main metabolites in human whole blood using LC-MS/MS.
    Haage P; Kronstrand R; Carlsson B; Kugelberg FC; Josefsson M
    J Pharm Biomed Anal; 2016 Feb; 119():1-9. PubMed ID: 26625281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection.
    Chytil L; Matousková O; Cerná O; Pokorná P; Vobruba V; Perlík F; Slanar O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):481-6. PubMed ID: 20018572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomeric determination of tramadol and O-desmethyltramadol by liquid chromatography- mass spectrometry and application to postoperative patients receiving tramadol.
    Musshoff F; Madea B; Stuber F; Stamer UM
    J Anal Toxicol; 2006 Sep; 30(7):463-7. PubMed ID: 16959140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CYP2D6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients.
    Suzuki K; Naito T; Tanaka H; Shibata K; Yamada Y; Itoh K; Kawakami J
    Basic Clin Pharmacol Toxicol; 2021 Mar; 128(3):472-481. PubMed ID: 33131142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
    Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography. Application to a pharmacokinetic study in humans.
    Campanero MA; García-Quetglas E; Sádaba B; Azanza JR
    J Chromatogr A; 2004 Mar; 1031(1-2):219-28. PubMed ID: 15058586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
    Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
    Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enatiomeric determination of tramadol and O-desmethyltramadol in human urine by gas chromatography-mass spectrometry.
    Chytil L; Stícha M; Matousková O; Perlík F; Slanar O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1937-42. PubMed ID: 19482526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of tramadol, O-desmethyltramadol and N-desmethyltramadol in human urine by gas chromatography-mass spectrometry.
    El-Sayed AA; Mohamed KM; Nasser AY; Button J; Holt DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():9-15. PubMed ID: 23542669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics.
    Godoy AL; De Moraes NV; Martinez EZ; Carvalho TM; Marques MP; Lanchote VL
    Chirality; 2011 Apr; 23(4):287-93. PubMed ID: 21384434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Pharm Biomed Anal; 2009 Feb; 49(2):354-66. PubMed ID: 19062215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomeric separation of tramadol and its active metabolite in human plasma by chiral high-performance liquid chromatography: application to pharmacokinetic studies.
    Campanero MA; Calahorra B; Valle M; Troconiz IF; Honorato J
    Chirality; 1999; 11(4):272-9. PubMed ID: 10224654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of
    Haage P; Kronstrand R; Josefsson M; Calistri S; van Schaik RHN; Green H; Kugelberg FC
    Pharmacol Res Perspect; 2018 Jul; 6(4):e00419. PubMed ID: 29992026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
    García Quetglas E; Azanza JR; Cardenas E; Sádaba B; Campanero MA
    Biopharm Drug Dispos; 2007 Jan; 28(1):19-33. PubMed ID: 17061296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous LC-MS/MS quantification of oxycodone, tramadol and fentanyl and their metabolites (noroxycodone, oxymorphone, O- desmethyltramadol, N- desmethyltramadol, and norfentanyl) in human plasma and whole blood collected via venepuncture and volumetric absorptive micro sampling.
    Al-Qurain AA; Williams DB; Mackenzie L; Roberts MS; Wiese MD
    J Pharm Biomed Anal; 2021 Sep; 203():114171. PubMed ID: 34087551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tramadol and metabolites O-desmethyltramadol and N-desmethyltramadol in adult horses.
    Stewart AJ; Boothe DM; Cruz-Espindola C; Mitchum EJ; Springfield J
    Am J Vet Res; 2011 Jul; 72(7):967-74. PubMed ID: 21728858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.